… When DEBs were used to treat SFA lesions, the occurrence of restenosis increased by 50% …
for the treatment of SFA ISR at our institution (of a total of 308 SFA interventions). Patients …

… In conclusion, paclitaxel-coated balloons do provide … SFA-ISR, especially for longer lesions.
Furthermore, these data suggest that PTA has outrun its usefulness as a comparator for SFA-…

… stents in SFA lesions are not well studied, we examined clinical outcome, patency and device
integrity after stenting long lesions … -expanding stents, covered stents, drug-eluting stents, …

… III lesion started at the CFA and extends to both the SFA and … -dilatation which was resolved
quickly using a covered stent. … CFA lesion (ie, groups III and IV) ten patients received stent …

… , femoropopliteal lesions in Japanese patients are treated primarily with PTA and stents. …
patients, and include bio-mimetic stents, atherectomy, covered stents, and other DCBs (MIMICS-…

… superior outcomes or the lesion characteristics for which each stent is more suitable. The …
Eluvia drug eluting stent and Viabahn stent graft for femoropopliteal artery lesions) study was to …

… from 38 patients who received nitinol stent implantation for SFA lesions were also excluded
… Recently, Zilver-PTX stent, which has coated paclitaxiel without polymer, has been shown to …

… a new-generation stent for the treatment of obstructive lesions of the SFA/PPA in patients …
, atherectomy, bare nitinol stents, covered stents, drug-coated balloons, and drug-eluting …

… -coated balloons (DCBs) and drug-eluting stents (DESs) the winners at the moment. Even for
the more challenging lesions, such as long lesions, occlusions, and in-stent … covered stents …

… restenotic lesions in the SFA/PPA. The trial was designed to be part of a series including
IN.PACT … In our trial, the provisional stent rate was very low despite the presence of longer …